| 摘要 |
<p num="1"><br/><br/><br/>Preferred embodiments of the present invention are related to novel <br/>therapeutic drug combinations and methods for treating pulmonary arterial <br/>hypertension. More particularly, aspects of the present invention are related <br/>to using a combination of iloprost and at least one additional agent, selected <br/>from the group consisting of an endothelin receptor antagonist and a PDE <br/>inhibitor.<br/>
|
